Position in GERN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$776,243
-$540,313 QoQ
Shares Held
606,440
-31.4% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 258 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. GERN ranks #102 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in GERN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $776,243 | 606,440 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,316,556 | 883,595 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,084,894 | 821,890 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,351,304 | 986,354 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,168,197 | 828,509 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,401,755 | 881,607 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,260,683 | 1,203,583 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,464,978 | 1,424,004 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4,101,971 | 967,446 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $7,956,996 | 2,411,211 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,521,773 | 1,669,087 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,032,803 | 1,902,266 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,252,749 | 1,324,844 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $4,002,855 | 1,844,634 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,097,249 | 1,279,855 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,291,541 | 551,941 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $532,921 | 343,820 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $859,018 | 631,631 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $694,555 | 569,308 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $533,964 | 389,755 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $627,582 | 445,094 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,222,436 | 773,694 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $194,558 | 122,364 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $472,373 | 271,479 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||